BioAge Labs (BIOA) Non Operating Income (2023 - 2026)
BioAge Labs (BIOA) reported Non Operating Income of $3.1 million for Q1 2026, down 11.26% on a YoY basis from $3.5 million in Q1 2025, and up 25.89% sequentially from $2.5 million in Q4 2025.
BioAge Labs (BIOA) Non Operating Income (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Non Operating Income data on file, last reported at $3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 11.26% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 9.25% YoY), and the FY2025 full-year result was $12.2 million, up 71.84% from the prior year.
- Non Operating Income grew to $3.1 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.2 million in Q4 2024 to a low of -$7.4 million in Q4 2023.
- A 4-year average of $934727.3 and a median of $2.5 million in 2025 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 2065.36% in 2025, while the deepest fall reached 41.41% in 2025.
- Tracing BIOA's Non Operating Income over 4 years: stood at -$7.4 million in 2023, then soared by 157.5% to $4.2 million in 2024, then sank by 41.41% to $2.5 million in 2025, then gained by 25.89% to $3.1 million in 2026.
- Business Quant data shows BIOA's Non Operating Income at $3.1 million in Q1 2026, $2.5 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.23 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | -179,000.00 |
| Dec 31, 2023 | -7.36 Mn |
| Sep 30, 2023 | -4.74 Mn |